Last updated on November 2017

Minerva Pivotal Trial


Brief description of study

Minerva Pivotal Trial

Detailed Study Description

The study gathers information about a new medical device that has been developed to perform endometrial ablations. Women who suffer from excessive menstrual bleeding are randomized to the new device or a control device used to perform the endometrial ablation. Patients are followed for 3 years after the procedure.

Clinical Study Identifier: TX2199

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Cathy Frisinger

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »